Forecast of Global Intravesical Bacillus Calmette Players Market 2023

Global Intravesical Bacillus Calmette Market will register a 4.5% CAGR in terms of revenue, reach US$ 310 million by 2023, from US$ 240 million in 2017. Intravesical Bacillus Calmette is used to treat a certain type of bladder cancer. Bladder cancer is the growth of abnormal or cancerous cells on the inner lining of the bladder wall. BCG helps prevent the cancer from coming back in the bladder lining, and also reduces the risk of it becoming invasive.